Germany's decision rule for setting ceiling prices of drugs: a comparative analysis with other decision rules.

abstract：:The rapid rise in pharmaceutical costs in France has been driven by new technologies and the growing prevalence of chronic diseases as well as considerable prescribing freedom and choice of physician among patients. This has led to the introduction of a number of reforms and initiatives in an attempt to moderate expen...

journal_title：Applied health economics and health policy

authors： Sermet C,Andrieu V,Godman B,Van Ganse E,Haycox A,Reynier JP

更新日期：2010-01-01 00:00:00

abstract：:We conducted a scoping review with the objective of synthesizing available literature and mapping what designs and methods have been used to evaluate health insurance reforms in sub-Saharan Africa. We systematically searched for scientific and grey literature in English and French published between 1980 and 2017 using...

journal_title：Applied health economics and health policy

authors： Degroote S,Ridde V,De Allegri M

更新日期：2020-12-01 00:00:00

abstract：OBJECTIVES:To analyse the cost effectiveness of community-based case management for patients suffering from chronic obstructive pulmonary disease (COPD). METHODS:The study took place in the third largest municipality in Denmark and was conducted as a randomised controlled trial with 12 months of follow-up. A total of ...

journal_title：Applied health economics and health policy

authors： Sørensen SS,Pedersen KM,Weinreich UM,Ehlers L

更新日期：2017-06-01 00:00:00

abstract：AIM:To assess the relative cost effectiveness of four strategies (academic detailing, computerised reminder systems, target payments and interactive continuing medical education) to increase the provision of screening and brief interventions by Australian GPs with the ultimate goal of decreasing risky alcohol consumpti...

journal_title：Applied health economics and health policy

authors： Shanahan M,Shakeshaft A,Mattick RP

更新日期：2006-01-01 00:00:00

abstract：:The Peristeen transanal irrigation system is intended to allow people with bowel dysfunction to flush out the lower part of the bowel as part of their bowel management strategy. Peristeen was the subject of an evaluation by the National Institute for Health and Care Excellence, through its Medical Technologies Evaluat...

journal_title：Applied health economics and health policy

authors： Dale M,Morgan H,Carter K,White J,Carolan-Rees G

更新日期：2019-02-01 00:00:00

abstract：:Smoking of tobacco products is a major public health challenge in prison settings in most countries. Although tobacco use was tolerated by custodial authorities for many decades, the overwhelming evidence of the adverse public health effects of tobacco on both the smokers and those in the vicinity of exhaled or passiv...

journal_title：Applied health economics and health policy

authors： Awofeso N

更新日期：2002-01-01 00:00:00

abstract：BACKGROUND:Although suicide-prevention campaigns have been implemented in numerous countries, Canada has yet to implement a strategy nationally. This is the first study to examine the cost utility of the implementation of a multidimensional suicide-prevention program that combines several interventions over a 50-year t...

journal_title：Applied health economics and health policy

authors： Lebenbaum M,Cheng J,de Oliveira C,Kurdyak P,Zaheer J,Hancock-Howard R,Coyte PC

更新日期：2020-04-01 00:00:00

abstract：OBJECTIVE:Compared to traditional drugs, specialty drugs tend to be indicated for lower prevalence diseases. Our objective was to compare the potential population health benefits associated with specialty and traditional drugs in the year following product approval. METHODS:First, we created a dataset of estimates of ...

journal_title：Applied health economics and health policy

authors： Chambers JD,Thorat T,Wilkinson CL,Salem M,Subedi P,Kamal-Bahl SJ,Neumann PJ

更新日期：2017-04-01 00:00:00

abstract：OBJECTIVE:To develop a statistical model generating utility estimates for prostate cancer specific health states, using preference weights derived from the perspectives of prostate cancer patients, men at risk for prostate cancer, and society. METHODS:Utility estimate values were calculated using standard gamble (SG) ...

journal_title：Applied health economics and health policy

authors： Gries KS,Regier DA,Ramsey SD,Patrick DL

更新日期：2017-06-01 00:00:00

abstract：BACKGROUND AND OBJECTIVE:Opinions on the use of research abstracts in policy decision making are conflicting. We sought to evaluate the influence of research abstracts in guiding decisions of the Joint Oncology Drug Review of Canada (JODR), which conducts clinical and economic reviews of new cancer treatment drugs for ...

journal_title：Applied health economics and health policy

authors： Weizman AV,Griesman J,Bell CM

更新日期：2010-01-01 00:00:00

abstract：:Smoking is an expensive habit. Smoking households spend, on average, more than $US1000 annually on cigarettes. When a family member quits, in addition to the former smoker's improved long-term health, families benefit because savings from reduced cigarette expenditures can be allocated to other goods. For households i...

journal_title：Applied health economics and health policy

authors： Busch SH,Jofre-Bonet M,Falba TA,Sindelar JL

更新日期：2004-01-01 00:00:00

abstract：:Memokath-051 is a thermo-expandable, nickel-titanium alloy spiral stent used to treat ureteric obstruction resulting from malignant or benign strictures. The National Institute for Health and Care Excellence (NICE) selected Memokath-051 for evaluation. The company, PNN Medical, claimed Memokath-051 has clinical superi...

journal_title：Applied health economics and health policy

authors： Eaton Turner E,Jenks M,McCool R,Marshall C,Millar L,Wood H,Peel A,Craig J,Sims AJ

更新日期：2018-08-01 00:00:00

abstract：BACKGROUND:Updated treatment guidelines for atrial fibrillation (AF) have been released by the National Institute for Health and Care Excellence (NICE) in the UK, and highlight a current shortfall in the prescription of anticoagulants to patients with AF for stroke prevention. OBJECTIVE:To design a budget impact model...

journal_title：Applied health economics and health policy

authors： Shields GE,Bates AE,Chapman AM

更新日期：2015-10-01 00:00:00

abstract：:There is wide consensus that the ways in which providers are reimbursed by third parties will affect their behaviour and, hence, the efficient use of limited resources and the performance of health systems. However, there seems to be little evidence on how payment to hospital-based doctors affects hospital performance...

journal_title：Applied health economics and health policy

authors： Liu X,Mills A

更新日期：2003-01-01 00:00:00

abstract：BACKGROUND:Pricing drugs in the California Workers' Compensation System (CAWCS) has become more difficult as there are increasingly fewer drugs listed in the Medi-Cal primary fee schedule, which is used as the source for CAWCS drug prices. This presents a challenge of providing timely and accurate CAWCS reimbursement. ...

journal_title：Applied health economics and health policy

authors： Wilson L,Turkistani F,Tran DM,Huang W,Lin TK

更新日期：2019-04-01 00:00:00

abstract：BACKGROUND:The management of the large patient population in Italy receiving long-term oral anticoagulation therapy (OAT) poses organizational challenges that are traditionally approached with a centralized procedure, relying on hospital-based clinics and/or GPs. However, the availability of near-patient testing device...

journal_title：Applied health economics and health policy

authors： Pradelli L,Iannazzo S,Zaniolo O,Botrugno P

更新日期：2010-01-01 00:00:00

abstract：BACKGROUND:Mental health problems are highly prevalent among college students in many countries. However, evidence suggests that many at-risk students do not receive professional help. OBJECTIVE:We aimed to understand which students are most likely to have unmet need for mental health services. Given increasing and wi...

journal_title：Applied health economics and health policy

authors： Cullinan J,Walsh S,Flannery D

更新日期：2020-04-01 00:00:00

abstract：:Central line-associated bloodstream infections (CLABSIs) are primary, laboratory confirmed bloodstream infections in patients with a central line within 48 h of symptom onset. Catheter-related bloodstream infection (CRBSI) is a more specific term used when the cause of infection has been confirmed by catheter tip cult...

journal_title：Applied health economics and health policy

authors： O'Connell S,Dale M,Morgan H,Carter K,Carolan-Rees G

更新日期：2020-08-05 00:00:00

abstract：:The mandatory nature of recommendations made by the National Institute for Health and Clinical Excellence (NICE) in the UK has highlighted inherent difficulties in the process of disinvestment in existing technologies to fund NICE-approved technologies. A lack of evidence on candidate technologies means that the proce...

journal_title：Applied health economics and health policy

authors： Karnon J,Carlton J,Czoski-Murray C,Smith K

更新日期：2009-01-01 00:00:00

abstract：:The debate surrounding whether the findings of efficacy studies are applicable to real-world treatment situations is ongoing. The issue of lack of applicability due to a lack of clinical heterogeneity could be addressed by employing less restrictive inclusion criteria. Given that health economic assessments based on c...

journal_title：Applied health economics and health policy

authors： Richter A,Thieda P,Thaler K,Gartlehner G

更新日期：2011-05-01 00:00:00

abstract：BACKGROUND:Decision makers within the Calgary Health Region adopted and applied programme budgeting and marginal analysis (PBMA) for priority-setting activity across major service portfolios within the Region. METHODS:Seventeen in-depth qualitative interviews were conducted with senior managers and clinicians to gain ...

journal_title：Applied health economics and health policy

authors： Mitton C,Patten S,Donaldson C

更新日期：2004-01-01 00:00:00

abstract：BACKGROUND:Patients with venous thromboembolism (VTE) commonly have an underlying genetic predisposition. However, genetic tests nowadays in use have very low sensitivity for identifying subjects at risk of VTE. Thrombo inCode(®) is a new genetic tool that has demonstrated very good sensitivity, thanks to very good cov...

journal_title：Applied health economics and health policy

authors： Rubio-Terrés C,Soria JM,Morange PE,Souto JC,Suchon P,Mateo J,Saut N,Rubio-Rodríguez D,Sala J,Gracia A,Pich S,Salas E

更新日期：2015-04-01 00:00:00

abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is the second most common cancer in Taiwan. For males in Taiwan, it is the most dangerous cancer, with both the highest incidence and mortality rate. OBJECTIVE:To determine cancer-related medical care costs for long-term survivors of HCC. METHODS:The estimation of the lifetim...

journal_title：Applied health economics and health policy

authors： Lang HC,Wu JC,Yen SH,Lan CF,Wu SL

更新日期：2008-01-01 00:00:00

abstract：BACKGROUND:European guidelines advocate the measurement of on-treatment hepatitis C virus (HCV) RNA in order to determine optimal therapy duration (response-guided therapy [RGT]) in patients with rapid virological response (RVR) or delayed virological response (DVR). Treatment response is highly dependent upon the exte...

journal_title：Applied health economics and health policy

authors： McEwan P,Kim R,Yuan Y

更新日期：2013-02-01 00:00:00

abstract：:The South Korean Government recently announced a reform in the drug anti-rebate law, with the purpose of eradicating pervasive, unethical, and illegal rebate practices in pharmaceutical marketing. The main objective of this reform is to have the ability to bring criminal charges against doctors and pharmacists for rec...

journal_title：Applied health economics and health policy

authors： Yu SY,Yang BM,Kim JH

更新日期：2013-08-01 00:00:00

abstract：OBJECTIVE:Several EU countries are determining reimbursement prices of pharmaceuticals by cross-referencing prices of foreign countries. Our objective is to quantify the theoretical cross-border spill-over effects of cross-reference pricing schemes on pharmaceutical prices in the former EU-15 countries. METHODS:An ana...

journal_title：Applied health economics and health policy

authors： Stargardt T,Schreyögg J

更新日期：2006-01-01 00:00:00

abstract：BACKGROUND:Chronic obstructive pulmonary disease (COPD) affects approximately 3 million people in the UK. An 8-week pulmonary rehabilitation (PR) course is recommended under current guidelines. However, studies show that initial benefits diminish over time. OBJECTIVE:We present here an economic evaluation conducted al...

journal_title：Applied health economics and health policy

authors： Burns DK,Wilson EC,Browne P,Olive S,Clark A,Galey P,Dix E,Woodhouse H,Robinson S,Wilson A

更新日期：2016-02-01 00:00:00

abstract：BACKGROUND:In virologically suppressed patients, switching to darunavir/ritonavir (DRV/r) monotherapy maintains HIV RNA suppression, and could also lower treatment costs. OBJECTIVE:The purpose of this analysis was to calculate the potential cost savings from the use of DRV/r monotherapy in the UK. METHODS:In the MONE...

journal_title：Applied health economics and health policy

authors： Gazzard B,Hill A,Anceau A

更新日期：2011-07-01 00:00:00

abstract：BACKGROUND:Osteoporosis is recognized as a serious health condition in developed as well as developing countries. There are no accurate estimates of the extent of the burden of osteoporosis in New Zealand. The purpose of this study was to estimate the economic burden of osteoporosis in New Zealand using data from inter...

journal_title：Applied health economics and health policy

authors： Brown P,McNeill R,Leung W,Radwan E,Willingale J

更新日期：2011-03-01 00:00:00

abstract：BACKGROUND:Employers are increasingly relying on rewards programmes in an effort to promote greater levels of activity among employees; however, if enrolment in these programmes is dominated by active employees, then they are unlikely to be a good use of resources. OBJECTIVE:This study uses a stated-preference survey ...

journal_title：Applied health economics and health policy

authors： Ozdemir S,Bilger M,Finkelstein EA

更新日期：2017-10-01 00:00:00